Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Rheumatology
Scleritis
Questions discussed in this category
How would you approach management of nodular scleritis in the setting of suspected GCA?
Can nodular scleritis be a presenting manifestation of GCA?
1 Answer available
What is your approach to management of ongoing scleritis in SLE despite mycophenolate?
1 Answer available
What is your approach to evaluation of underlying autoimmune disease in patients with bilateral scleromalacia?
1 Answer available
Are there any situations in which you would consider starting steroid-sparing agents at the outset for patients with scleritis without any evidence of systemic rheumatic disease?
2 Answers available
21397
13883
11565
8466
Papers discussed in this category
Ophthalmology, 2014-10
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.
Lupus,
Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
Br J Ophthalmol, 2015 Apr 22
Ocular manifestations in systemic lupus erythematosus.
Am J Ophthalmol,
Episcleritis and scleritis: clinical features and treatment results.
Transplant Proc,
A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney transplant recipients at a single institute in China.
Related Topics in Rheumatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers